Loading your page…

Pharmaceutical group

Madrigal

9 medicines5 countries

A group of 3 companies with 9 medicines in 5 countries.

Its medicines

Group structure

3 companies in 3 countries

Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.

Medicines

Every medicine of every company in the group, current ones first.

9 medicines

Medicine	Substance	Country	Status	Authorised
REZDIFFRACompressa rivestita con film	Resmetirom	Italy	Authorised
Rezdiffra	Resmetirom	EU (EMA)	Authorised	2025
REZDIFFRA100mg \| 60mg \| 80mg · Tablet	Resmetirom	United States	Marketed	2024
REZDIFFRA 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA100 mg · Comprimido recubierto con película	Resmetirom	Spain	Authorised	2025
Rezdiffra 100 mg filmomhulde tablettenFilmomhulde tablet	Resmetirom	Netherlands	Authorised	2025
REZDIFFRA 60 MG COMPRIMIDOS RECUBIERTOS CON PELICULA60 mg · Comprimido recubierto con película	Resmetirom	Spain	Authorised	2025
Rezdiffra 60 mg filmomhulde tablettenFilmomhulde tablet	Resmetirom	Netherlands	Authorised	2025
REZDIFFRA 80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA80 mg · Comprimido recubierto con película	Resmetirom	Spain	Authorised	2025
Rezdiffra 80 mg filmomhulde tablettenFilmomhulde tablet	Resmetirom	Netherlands	Authorised	2025

Sources and licences

Country	Medicines	Current	Companies
Spain	3	3	Companies All medicines
Netherlands	3	3	Companies All medicines
European Union (EMA)	1	1	Companies All medicines
Italy	1	1	Companies All medicines
United States	1	1	Companies All medicines

Compiled by Prognia from the public medicine and company registers below. Logos are not used.

Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.

European Medicines Agency

Source: European Medicines Agency (EPAR data).

Licence: EMA reuse policy (source acknowledgement required)

Agencia Española de Medicamentos y Productos Sanitarios (CIMA)

Fuente de la información: AEMPS (CIMA).

Licence: AEMPS open data reuse with attribution

U.S. Food and Drug Administration (Drugs@FDA, openFDA)

Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.

Licence: Public domain (U.S. Government work)

Base de données publique des médicaments (ANSM, HAS, UNCAM)

Source: BDPM (ANSM, HAS, UNCAM).

Licence: Licence Ouverte v1.0

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required

All 11 sources

BDPM / ANSM, HAS and UNCAM

BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained

Licence: BDPM exact Licence Ouverte v1.0 (October 2011)

Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom

Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.

Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom

Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; October 2026 published list; https://assets.publishing.service.gov.uk/media/6ac65fc6f1ba855cc196a8ba/New_Manufacturing_and_Wholesale_Dealer_Licences_-_October_2026.csv; acquired 2026-10-14T16:17:18.644817+00:00; CSV-to-licence-event projections are adaptations under OGL v3.0.

Licence: Open Government Licence v3.0; Crown copyright MHRA published licence history

Agenzia Italiana del Farmaco (AIFA), Italy

Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.

Licence: CC BY 4.0; AIFA published open-data catalog

College ter Beoordeling van Geneesmiddelen

College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.

Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim

Report an error or request removalCorrections from the company itself are welcome.

Madrigal

Group structure

Ireland1

United Kingdom1

United States1

Medicines

Know your medicines, with the sources.

Madrigal

Group structure

Ireland1

United Kingdom1

United States1

Medicines

Know your medicines, with the sources.

Countries

Therapeutic areas

Top substances

Names in the registers

Sources and licences

At a glance

Other big groups

Group structure

🇮🇪Ireland1

🇬🇧United Kingdom1

🇺🇸United States1

Medicines

Know your medicines, with the sources.

Group structure

🇮🇪Ireland1

🇬🇧United Kingdom1

🇺🇸United States1

Medicines

Know your medicines, with the sources.

Countries

Therapeutic areas

Top substances

Names in the registers

Sources and licences

At a glance

Ireland1

United Kingdom1

United States1

Ireland1

United Kingdom1

United States1